ACH
|
Acetylcholine |
BONT
|
Botulinum toxin |
BONT-A
|
Botulinum toxin serotype A |
BONT-B
|
Botulinum toxin serotype B |
CGRP
|
Calcitonin gene-related peptide |
CM
|
Chronic migraine |
CNS
|
Central nervous system |
DA
|
Dalton |
E2
|
Estradiol |
EM
|
Episodic migraine |
FDA
|
Food and Drug Administration |
FHM
|
Familial hemiplegic migraine |
FSH
|
Follicular-stimulant hormone |
HC
|
Heavy chain |
IL
|
Interleukin |
LC
|
Light chain |
MA
|
Migraine with aura |
MIDAS
|
Migraine Disability Assessment |
MO
|
Migraine without aura |
MU
|
Mouse Units |
NO
|
Nitric Oxide |
NOS
|
Nitric oxide synthase |
NSAID
|
Non-steroidal anti-inflammatory drug |
PREEMPT
|
Phase III Research Evaluating Migraine Prophylaxis Therapy |
QOL
|
Quality of Life |
SNAP-25
|
Synaptosomal-associated protein-25 kDa |
SNARE
|
Soluble NSF attachment protein receptor |
SP
|
Substance P |
TNF-
A
|
Tumor necrosis factor alpha |
TRP
|
Transient receptor potential channel |
TRPA1
|
Transient receptor potential ankyrin 1 |
TRVP1
|
Transient receptor potential cation channel subfamily V member 1 |
VAMP
|
Vesicle-associated membrane protein |
WHO
|
World Health Organization |